Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
2.230
-0.080 (-3.46%)
Nov 3, 2026, 12:46 PM EST - Market open
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $2.94 million as of November 3, 2026. It is the 46,706th most valuable company in the world and the 6,223rd biggest in the United States. Its market cap has decreased by 94.28% in one year.
Market Cap
2.94M
Enterprise Value
3.17M
1-Year Change
-94.28%
Global Rank
Country Rank
#6,223 United States
Category
ChartMarket Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $2.94M, a decrease of -97.78%. That is a compound annual growth rate of -86.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 2.94M | -91.63% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 3.44M |
| PharmaCyte Biotech | 3.44M |
| GRI Bio | 3.28M |
| KALA BIO | 3.27M |
| 60 Degrees Pharmaceuticals | 3.18M |
| Eocene | 3.12M |
| Mustang Bio | 3.10M |
| Dermata Therapeutics | 2.95M |